Rice Bran Oil and γ‐Oryzanol in the Treatment of Hyperlipoproteinaemias and Other Conditions
- 8 June 2001
- journal article
- review article
- Published by Wiley in Phytotherapy Research
- Vol. 15 (4), 277-289
- https://doi.org/10.1002/ptr.907
Abstract
Diet is the first (and sometimes the only) therapeutic approach to hyperlipoproteinaemias. Rice bran oil and its main components (unsaturated fatty acids, triterpene alcohols, phytosterols, tocotrienols, α‐tocopherol) have demonstrated an ability to improve the plasma lipid pattern of rodents, rabbits, non‐human primates and humans, reducing total plasma cholesterol and triglyceride concentration and increasing the high density lipoprotein cholesterol level. Other potential properties of rice bran oil and γ‐oryzanol, studied both in vitro and in animal models, include modulation of pituitary secretion, inhibition of gastric acid secretion, antioxidant action and inhibition of platelet aggregation. This paper reviews the available data on the pharmacology and toxicology of rice bran oil and its main components with particular attention to those studies relating to plasma lipid altering effects. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 80 references indexed in Scilit:
- Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanolThe Journal of Pediatrics, 1993
- Commercially Marketed Supplements for Bodybuilding AthletesSports Medicine, 1993
- Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: a review.Journal of the American College of Nutrition, 1991
- DNA-damaging, mutagenic, clastogenic and cell-cell communication inhibitory properties of .GAMMA.-Oryzanol.The Journal of Toxicological Sciences, 1991
- Polychlorinated Biphenyls, Dibenzofurans and Quaterphenyls in Toxic Rice-Bran Oil and in the Blood and Tissues of Patients with PCB Poisoning (Yu-Cheng) in TaiwanEnvironmental Health Perspectives, 1985
- Reaction of biological phenolic antioxidants with superoxide generated by cytochrome P-450 model systemBiochemical and Biophysical Research Communications, 1983
- Effects of .GAMMA.-oryzanol on lipid metabolism in rats fed high-cholesterol diet.The Tohoku Journal of Experimental Medicine, 1983
- Absorption and metabolism of .GAMMA.-oryzanol in rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Inhibition of LH Secretion by Gamma-Oryzanol in RatHormone and Metabolic Research, 1981
- Effect of .GAMMA.-oryzanol on serum TSH concentrations in primary hypothyroidism.Endocrinologia Japonica, 1980